London shares leapt out of the blocks this morning on the hope that global trade tensions could recede. Click here for The Trader Nicole Elliott's latest thoughts on the markets.
IC TIP UPDATES:
Another day, another divestment of drug rights by AstraZeneca (AZN) as it continues to offload medicines it deems less important to its future growth. This time, the pharma giant has sold prescription medicine rights to stomach acid drug Nexium in Europe, as well as the global rights (excluding the US and Japan) to another stomach acid pain reliever Vimovo to German phama company Grünenthal. We remain sellers.